Company Projected Revenue: Precipio, Inc (PRPO)

PRPO (precipiodx.com) - company brandmark

The transition to digital reporting and compliance with environmental standards support the asset's stability, confirming the sales target for Precipio, Inc. (PRPO), where the current parameter equals 0.03. Precipio, Inc. (PRPO) generates revenue from B2B cancer diagnostics while expanding its market share. High authority among American pathologists is driven by biopsy accuracy, which minimizes medical errors.

PRPO - Precipio, Inc. Company Future Sales over the range 07/04/2022 - 11/13/2026

Precipio Inc. - analytical breakdowns and key metrics (PRPO)

- current price and projected stock value:
Stock Quotes Precipio, Inc.|PRPO - Average Forecast Price
- company stock exchange capitalization indicators:
Market Value Precipio Inc.|PRPO - Company Buyout Price
- balance sheet equity data:
Book Value per Share Precipio|PRPO - Book Valuation of Business|Market Value to Book Value Ratio precipiodx.com|PRPO - Company Total Asset Base
- debt and liquidity details:
Debt to Equity Precipio, Inc.|PRPO - Long-Term Liabilities to Equity|Short-Term Debt to Equity Precipio, Inc|PRPO - Aggregate Debt Obligations|Debts to Book Capitalization Precipio Inc.|PRPO - Long-Term Debt|Company Short-Term Debts Precipio|Quick Ratio precipiodx.com
- earnings and market ratios statistics:
PRPO - Net Financial Result|Expected Profit Precipio, Inc.|PRPO - Market Cap to Net Income|Forward P/E Multiple Precipio|PRPO - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Precipio Inc.|PRPO - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Precipio|PRPO - Earnings per share for the trailing year|Quarterly EPS earnings growth precipiodx.com|PRPO - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Precipio, Inc.
- revenue and sales proceeds data:
PRPO - Company Sales Volume|Projected Sales Volume Precipio, Inc.|PRPO - Market Cap to Revenue|Forward Price-to-Revenue Multiple Precipio Inc.
Fundamental valuation:Precipio, Inc.
Signature product of Precipio, Inc

Precipio, Inc. (PRPO) specialization in high-precision oncology diagnostics requires the continuous expansion of its partner clinic network. This metric digitizes expected cash flows, converting quarterly reports into a daily format for calculating future revenues. Such an approach allows for the real-time assessment of the business's operational resilience. Stable growth confirms the successful implementation of technologies, whereas stagnation may signal market saturation. By analyzing the company's revenue forecasts, an investor assesses the fundamental reliability of the issuer.

Competitors of Precipio, Inc. (PRPO)

Company Future Sales Volume CAI (Caris Life Sciences, Inc.)|GH - Company Expected Sales Volume|Company Projected Revenue Veracyte VCYT|Company Future Sales Celcuity Inc (CELC)|GRAIL Corp - Projected Sales Volume|Company Future Sales Myriad MYGN|Castle Biosciences (CSTL) - Company Projected Revenue|BNR - Company Future Sales|Company Projected Revenue VolitionRx Ltd.|Biodesix Inc - Company Expected Revenue|Company Projected Revenue Check-Cap Ltd. (CHEK)|MYNZ (mainzbiomed.com) - Company Future Revenue|Projected Sales Volume OCX (OncoCyte Corporation)